Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose evaluation of remimazolam during cardiopulmonary bypass
jRCT1011230015Recruiting
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of remimazolam. Primary endpoint: Concentration of free remimazolam. Started Jul 2023; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on jRCT1011230015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1011230015.